Latest Tremor Stories
At Scott & White Memorial Hospital, a multi-disciplinary team of neurosurgeons, neurologists, neurophysiologist, neuropsychologists and a movement disorders specialist are offering hope to some Parkinson's patients with a treatment called Deep Brain Stimulation (DBS).
Irregular arm swings while walking could be an early sign of Parkinson's disease.
Researchers at the Mayo Clinic campus in Florida and their collaborators worldwide have discovered that a single gene promotes development of essential tremor in some patients and Parkinson's disease in others.
A spike in mysterious underground rumblings observed on a section of the San Andreas fault near Parkfield, California, could indicate a build-up of stress and an increased likelihood of a major earthquake.
A clinical report from Dresden supports the impression that â€œSpice Goldâ€ is strongly addictive. In the current edition of Deutsches Ã„rzteblatt International (Dtsch Arzteblatt Int 2009: 106: 464-7), Ulrich S. Zimmermann, from Dresden Technical University, and his colleagues describe a young man who developed physical withdrawal symptoms after regular consumption of this designer drug, accompanied by a dependence syndrome.
U.S. scientists say they have genetically engineered mice to reproduce many of the non-motor symptoms associated with Parkinson's disease in humans. Emory University researchers said the classic symptoms of Parkinson's disease involve tremor, stiffness and slow movements.
SAN FRANCISCO, May 19 /PRNewswire/ -- New data demonstrate that maintenance therapy with RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Treatment (RLAT) significantly delayed the time to relapse compared to placebo in patients with Bipolar I Disorder.
Agreement opens clear path to NDA for early diagnosis of Parkinsonian Syndromes HOPKINTON, Mass., April 6 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc.
Largest Video Ad Network to Solidify Its Leadership Position with Accelerated Product Development and International Expansion NEW YORK, Feb.
HOPKINTON, Mass., Feb. 3 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE), announced today that it has completed enrollment in the first stage of the Altropane Parkinson's or Essential Tremor (POET-2) Phase III clinical program.
- A serpent whose bite was fabled to produce intense thirst.